Clinical Trial Update: Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating combination chemotherapy with bevacizumab for locally advanced, metastatic, or recurrent colorectal cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 3 | Status: TERMINATED